This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

'RealMoney' Radio Recap: Margins of Error

Jim Cramer saw some classic signs of a market bottom Thursday morning, but forced margin-selling came into play Thursday afternoon, wiping out chances for a bottom, he said on his "RealMoney" radio show .

"Too many people own too many hot stocks with margin debt," said Cramer. When that happens and stocks go down, borrowers must either send in more money to their brokers or the broker will sell the stock out from under them.

Most of the time, it's the latter that happens, he said. Forced margin selling usually begins around 2 o'clock, said Cramer, and sure enough, as the 2 o'clock hour approached, the market began to sell off.

Cramer said Thursday's action was reminiscent of what happened during the dramatic market declines of 2000, in the wake of the tech bubble. But, the difference this time, he said, is that most companies are real companies with real profits.

Thus, Cramer expects to begin seeing analysts upgrade beaten-down stocks. He also believes analysts whose estimates for oil are too low may start to raise their price targets. And, companies seeing their stock prices fall precipitously are more likely to start buying back stock.

For those who are on margin, though, said Cramer, "Get off margin right now. ... Margin is horrible."

In response to a question about Seagate Technology (STX - Get Report), Cramer said that the stock is a battleground and that there is a "lot of bad money in Seagate." It's "too hard," he said.

In response to a question about recent IPOs that are trading below their offering prices, Cramer said Avalon Pharmaceuticals (AVRX) is "kind of interesting." Caribou Coffee (CBOU) "doesn't have great earnings momentum," but if you buy it around $10 to $11, "you'll be OK," he said.

Cramer also mentioned Genomic Health (GHDX - Get Report) but said that "none of these jumps out at me as if you must own them," adding that "things are rough out there right now."
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ZOLT $0.00 0.00%
ELX $7.99 0.00%
GHDX $25.89 -1.70%
SLB $76.12 0.94%
STX $49.53 -0.48%

Markets

Chart of I:DJI
DOW 16,352.18 +0.80 0.00%
S&P 500 1,954.79 +5.93 0.30%
NASDAQ 4,749.4550 -0.5240 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs